Malta - English - Medicines Authority

astellas pharmaceuticals a.e.b.e 6-8 agisilaou str., 151 23 marousi, athens,, greece - tamsulosin hydrochloride - film-coated tablet prolonged-release tablet - tamsulosin hydrochloride 0.4 mg - urologicals

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tamsulosin hydrochloride, quantity: 400 microgram - tablet, modified release - excipient ingredients: quinoline yellow; purified talc; polyethylene oxide; cochineal; microcrystalline cellulose; magnesium stearate; hyprolose; butylated hydroxytoluene; macrogol 400; titanium dioxide; iron oxide black; hypromellose; colloidal anhydrous silica - for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

accord healthcare limited - amitriptyline (amitriptyline hydrochloride) - tablets film-coated - 25mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

accord healthcare limited - amitriptyline (amitriptyline hydrochloride) - tablets film-coated - 10mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tamsulosin hydrochloride, quantity: 400 microgram - tablet, modified release - excipient ingredients: quinoline yellow; purified talc; polyethylene oxide; cochineal; microcrystalline cellulose; magnesium stearate; hyprolose; butylated hydroxytoluene; macrogol 400; titanium dioxide; iron oxide black; hypromellose; colloidal anhydrous silica - for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tamsulosin hydrochloride, quantity: 400 microgram - tablet, modified release - excipient ingredients: quinoline yellow; purified talc; polyethylene oxide; cochineal; microcrystalline cellulose; magnesium stearate; hyprolose; butylated hydroxytoluene; macrogol 400; titanium dioxide; iron oxide black; hypromellose; colloidal anhydrous silica - for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - nortriptyline hydrochloride 11.4mg equivalent to nortriptyline base 10 mg - tablet - 10 mg - active: nortriptyline hydrochloride 11.4mg equivalent to nortriptyline base 10 mg excipient: lactose monohydrate magnesium stearate maize starch - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - nortriptyline hydrochloride 28.5mg equivalent to nortriptyline base 25 mg - tablet - 25 mg - active: nortriptyline hydrochloride 28.5mg equivalent to nortriptyline base 25 mg excipient: lactose monohydrate magnesium stearate maize starch - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states.

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - tamsulosin hydrochloride - prolonged-release tablet - 400 microgram(s) - alpha-adrenoreceptor antagonists; tamsulosin

Ireland - English - HPRA (Health Products Regulatory Authority)

astellas pharma co. limited - tamsulosin hydrochloride - prolonged-release tablet - 400 microgram(s) - alpha-adrenoreceptor antagonists; tamsulosin